Cerus reported $34.78M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Cerus USD 34.78M 2.98M Dec/2024
GRIFOLS EUR 1.55B 94M Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
Neogen USD 222.2M 7.7M Mar/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Quidel USD 646.2M 1.21B Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 83.43M 7.32M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Utah Medical Products USD 6.16M 447K Mar/2026